BioSpace News Archive

Increasing cases of neurological disorders, ongoing research activities, and private and government investments.

The growing incidence of eye diseases and advancements in technology are driving the market for Ophthalmic Devices.

Increasing prevalence of neurological disorders, the rise in geriatric population, and elevating demand for Neuromodulation in developing countries have resulted in boosting the Neuromodulation market.

An improvement in the healthcare sector in developing nations and advancement in technology, along with support from the government, has driven the demand for the market.

The increasing number of surgeries and rising number of hybrid operating rooms are driving the market for surgical boom.

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies.

Anivive, a pet health technology company transforming the therapeutic discovery and development process, received $500,000 in grant funding to continue research on the use of LAVERDIA™ -CA1 in the treatment of canine lymphoma.

Ovid Therapeutics Inc. (NASDAQ: OVID) today announced appointments to its board of directors and leadership team as well as a realignment of its workforce to focus on early-stage development activities, including the build out of its neuroscience programs

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the closing on July 7, 2021 of its initial public offering in the United States

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, and Linda Rubinstein, Chief Financial Officer, will participate in the following upcoming investor conferences in July